Z Orthop Unfall 2024; 162(01): 52-56
DOI: 10.1055/a-1865-0091
Original Article

Mid-term Follow-Up after Closed Reduction in Developmental Dysplastic Hips

Mittelfristige Nachuntersuchung geschlossen-reponierter, kongenital-dislozierter Säuglingshüften
1   Department of Orthopedic Surgery and Traumatology, University Hospital Cologne, Köln, Germany (Ringgold ID: RIN27182)
,
Robert Ossendorff
2   Department of Orthopedic Surgery and Traumatology, University Hospital Bonn, Bonn, Germany (Ringgold ID: RIN39062)
,
Rahel Bornemann
2   Department of Orthopedic Surgery and Traumatology, University Hospital Bonn, Bonn, Germany (Ringgold ID: RIN39062)
,
Kourosh Zarghooni
1   Department of Orthopedic Surgery and Traumatology, University Hospital Cologne, Köln, Germany (Ringgold ID: RIN27182)
,
Christian Dominik Peterlein
3   Department for Orthopeadic Surgery, Muhlenkreiskliniken, Minden, Germany (Ringgold ID: RIN39632)
,
Richard Placzek
2   Department of Orthopedic Surgery and Traumatology, University Hospital Bonn, Bonn, Germany (Ringgold ID: RIN39062)
› Author Affiliations

Abstract

Purpose Closed reduction and subsequent spica casting is the gold standard for treatment of unstable or dislocated developmental dysplastic hips (DDHs). There are few data on mid-term results after treatment of DDH, especially on closed reduction.

Methods Thirty-one consecutive patients with unstable or dislocated hips (n = 36) that were treated by fluoroscopic, contrast agent-supported closed reduction and spica casting were included and evaluated clinically and radiologically 2 and 5 years after treatment.

Results After 2 and 5 years, there were no significant differences between healthy and successfully treated hips that were detectable with respect to acetabular coverage (AC) angle, center-edge angle, and clinical stability of the hip. There was a significant difference at the 2-year follow-up between healthy hips and hips that needed to undergo secondary open reduction surgery (n = 4) with respect to the AC angle (p < 0.001).

Conclusion Closed reduction in DDHs results in acceptable clinical and radiological results in the mid-term follow-up. It remains unclear why some patients with subsequent sonographically matured hips show secondary deterioration and recurrence of dysplasia.

Zusammenfassung

Einleitung: Die geschlossene Reposition und anschließende Anlage eines Beckenbeingipses entspricht dem Goldstandard in der Therapie der instabilen oder luxierten dysplastischen Hüfte. Bisher sind nur wenige Daten verfügbar, die den klinisch-radiologischen Verlauf nach dieser Therapie im mittelfristigen Verlauf beschreiben.

Methoden Konsekutive Patienten mit instabilen oder luxierten Hüften (n = 36), die mittels kontrastmittelgestützter geschlossener Reposition und anschließender Beckenbeingipsanlage versorgt wurden, wurden zwei und fünf Jahre nach der Therapie klinisch und radiologisch nachuntersucht.

Ergebnisse Nach zwei und fünf Jahren ergab sich kein signifikanter Unterschied zwischen gesunden und erfolgreich therapierten Hüften hinsichtlich des AC-Winkels, des center-edge-Winkels und der klinischen Stabilität des Hüftgelenkes. Ein signifikanter Unterschied bestand bereits im Zweijahresverlauf zwischen gesunden und dysplastischen Hüften, die eine offene, sekundäre Operation benötigten (n = 4) im AC-Winkel (p < 0.001).

Schlussfolgerung Die geschlossene Reposition dysplastischer Hüften zeigt akzeptable klinische und radiologische Ergebnisse im mittelfristigen follow-up. Es ist unklar welche initial erfolgreich behandelten Patienten mit dann sonographisch reifen Hüften, sekundär eine nicht zufriedenstellende Ausreifung der Hüften erfahren.



Publication History

Received: 10 December 2021

Accepted after revision: 22 May 2022

Article published online:
15 July 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Loder RT, Skopelja EN. The epidemiology and demographics of hip dysplasia. Orthopedics 2011; 2011: 238607 DOI: 10.5402/2011/238607. (PMID: 24977057)
  • 2 Woodacre T, Ball T, Cox P. Epidemiology of developmental dysplasia of the hip within the UK: refining the risk factors. J Child Orthop 2016; 10: 633-642 DOI: 10.1007/s11832-016-0798-5. (PMID: 27866316)
  • 3 Lange AE, Lange J, Napp M. et al. Population-based study of the incidence of congenital hip dysplasia in preterm infants from the Survey of Neonates in Pomerania (SNiP). BMC Pediatr 2017; 17: 78 DOI: 10.1186/s12887-017-0829-5. (PMID: 28302080)
  • 4 Schilt M. Optimal age for hip sonography screening. Ultraschall Med 2001; 22: 39-47 DOI: 10.1055/S-2001-11249. (PMID: 11253555)
  • 5 Woodacre T, Dhadwal A, Ball T. et al. The costs of late detection of developmental dysplasia of the hip. J Child Orthop 2014; 8: 325-332 DOI: 10.1007/S11832-014-0599-7. (PMID: 24973899)
  • 6 Graf R. Fundamentals of sonographic diagnosis of infant hip dysplasia. J Pediatr Orthop 1984; 4: 735-740 DOI: 10.1097/01241398-198411000-00015. (PMID: 6392336)
  • 7 Graf R. The diagnosis of congenital hip-joint dislocation by the ultrasonic Combound treatment. Arch Orthop Trauma Surg 1980; 97: 117-133 DOI: 10.1007/BF00450934. (PMID: 7458597)
  • 8 Walter SG, Bornemann R, Koob S. et al. Closed reduction as therapeutic gold standard for treatment of congenital hip dislocation. Z Orthop Unfall 2020; 158: 475-480 DOI: 10.1055/a-0979-2346. (PMID: 31533169)
  • 9 Placzek R, Funk J, Druschel C. Congenital hip dysplasia in newborns : Clinical and ultrasound examination, arthrography and closed reduction. Oper Orthop Traumatol 2013; 25: 417-429 DOI: 10.1007/S00064-013-0237-4. (PMID: 24005570)
  • 10 Walter SG, Endler CHJ, Remig AC. et al. Risk factors for failed closed reduction in dislocated developmental dysplastic hips. Int Orthop 2020; 44: 2343-2348 DOI: 10.1007/s00264-020-04655-1. (PMID: 32488566)
  • 11 Busse J, Gasteiger W, Tönnis D. A new method for roentgenologic evaluation of the hip joint--the hip factor. Arch Orthop Unfallchir 1972; 72: 1-9 DOI: 10.1007/BF00415854. (PMID: 5020681)
  • 12 Zadeh H, Catterall A, Hashemi-Nejad A. et al. Test of stability as an aid to decide the need for osteotomy in association with open reduction in developmental dysplasia of the hip. J Bone Joint Surg Br 2000; 82: 17-27 DOI: 10.1302/0301-620X.82B1.9618. (PMID: 10697309)
  • 13 Scott E, Dolan L, Weinstein S. Closed Vs. Open Reduction/Salter Innominate Osteotomy for Developmental Hip Dislocation After Age 18 Months: Comparative Survival at 45-Year Follow-up. J Bone Joint Surg Am 2020; 102: 1351-1357 DOI: 10.2106/JBJS.19.01278. (PMID: 32769602)
  • 14 Kilsdonk I, Witbreuk M, Van Der Woude H. Ultrasound of the neonatal hip as a screening tool for DDH: how to screen and differences in screening programs between European countries. J Ultrason 2021; 21: e147-e153 DOI: 10.15557/JOU.2021.0024. (PMID: 34258040)
  • 15 Placzek R, Gathen M, Koob S. et al. Modified neck-lengthening osteotomy after Morscher in children and adolescents. Oper Orthop Traumatol 2018; 30: 379-386 DOI: 10.1007/S00064-018-0561-9. (PMID: 30091056)
  • 16 Druschel C, Heck K, Kraft C. et al. Modified PemberSal osteotomy technique with lyophilized human allograft. Oper Orthop Traumatol 2016; 28: 472-488 DOI: 10.1007/S00064-016-0468-2. (PMID: 27628762)
  • 17 Thaler M, Biedermann R, Lair J. et al. Cost-effectiveness of universal ultrasound screening compared with clinical examination alone in the diagnosis and treatment of neonatal hip dysplasia in Austria. J Bone Joint Surg Br 2011; 93: 1126-1130 DOI: 10.1302/0301-620X.93B8.25935.
  • 18 Zhang G, Li M, Qu X. et al. Efficacy of closed reduction for developmental dysplasia of the hip: midterm outcomes and risk factors associated with treatment failure and avascular necrosis. J Orthop Surg Res 2020; 15: 579 DOI: 10.1186/S13018-020-02098-3. (PMID: 33267908)
  • 19 Bajuife SJ, Shaalan MH, Dawood A. Treatment of Developmental Dysplasia of the Hip: Short and Mid-term Outcome in Alnoor Specialized Hospital. Orthop Muscular Syst 2018; 7: 4 DOI: 10.4172/2161-0533.1000260.
  • 20 Dornacher D, Lippacher S, Reichel H. et al. Mid-term results after ultrasound-monitored treatment of developmental dysplasia of the hips: to what extent can a physiological development be expected?. J Pediatr Orthop B 2013; 22: 30-35 DOI: 10.1097/BPB.0B013E32835957A1. (PMID: 23014065)
  • 21 Thomas S. A review of long-term outcomes for late presenting developmental hip dysplasia. Bone Joint J 2015; 97-B: 729-733 DOI: 10.1302/0301-620X.97B6.35395.
  • 22 Novais EN, Kestel LA, Carry PM. et al. Higher Pavlik Harness Treatment Failure Is Seen in Graf Type IV Ortolani-positive Hips in Males. Clin Orthop Relat Res 2016; 474: 1847-1854 DOI: 10.1007/S11999-016-4776-5. (PMID: 26975383)
  • 23 Kubo H, Pilge H, Holthoff J. et al. Poorer radiological outcome after delayed diagnosis and treatment in human position in Fettweis plaster cast in 93 unstable hip joints type D, III and IV according to Graf. J Child Orthop 2018; 12: 590-598 DOI: 10.1302/1863-2548.12.180132. (PMID: 30607206)
  • 24 Von Kries R, Ihme N, Oberle D. et al. Effect of ultrasound screening on the rate of first operative procedures for developmental hip dysplasia in Germany. Lancet 2003; 362: 1883-1887 DOI: 10.1016/S0140-6736(03)14957-4. (PMID: 14667743)
  • 25 Novais E, Sanders J, Kestel L. et al. Graf Type-IV Hips Have a Higher Risk of Residual Acetabular Dysplasia at 1 Year of Age Following Successful Pavlik Harness Treatment for Developmental Hip Dysplasia. J Pediatr Orthop 2018; 38: 498-502 DOI: 10.1097/BPO.0000000000000875. (PMID: 27662383)